Firstunion Dual Heating System HTP “Biheat” Launches at InterTabac, Germany

Sep.18.2025
CFU launched the Biheat HTP series at InterTabac in Germany, featuring the world’s first dual-heating system combined with AI control and a 3.42-inch display, enabling multi-dimensional collaborative heating and personalized temperature adjustment, with each stick delivering over 40% more puffs than traditional solutions.

Leading vaporization company Firstunion unveiled its new Biheat Series HTP products during the InterTabac trade fair in Germany. The series introduces a Dual Heating System to HTP for the first time, integrating multiple heating methods to deliver multi-dimensional heating synergy. Biheat raises puffs per tobacco stick to 20+, more than 40% higher than conventional solutions.

 

Firstunion Dual Heating System HTP “Biheat” Launches at InterTabac, Germany
Image source: Firstunion Group

 

In addition, the Biheat Series is equipped with an AI model and an HD interactive display of up to 3.42 inches. The system can learn users’ puffing habits in real time and dynamically adjust temperature. The smart screen supports voice interaction and serves as a health management hub, while an AI assistant provides a personalized Q&A experience.

 

Firstunion Dual Heating System HTP “Biheat” Launches at InterTabac, Germany
Image source: Firstunion Group

 

Firstunion disclosed that it has laid out over 2,000 patents in the HTP field, including more than 200 international PCT patents. The products will launch first across the broader Asia-Pacific region.

 

Next, 2Firsts will present an exclusive interview with Firstunion, providing an in-depth look at the development logic and market prospects of this new technology.

 

For more on-the-ground coverage, visit the 2Firsts InterTabac Special Section.

 

Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
Opinion | As EU Reviews Tobacco Rules, Experts Warn Against Overlooking Smokers’ Alternatives
As the European Commission reviews its tobacco and advertising rules, two experts who provided written comments to 2Firsts argue that future EU policy should not overlook adult smokers’ alternatives. Dr Garrett McGovern and Dr Carmen Escrig say regulators should weigh relative risk, adult switching, flavours, consumer behaviour and scientific uncertainty alongside youth protection.
Industry Insight
Jun.01
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
 Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
Philip Morris Lowers Profit Outlook as Zyn Faces Competition and FDA Delays
According to Reuters, Philip Morris International (PMI) lowered its 2026 adjusted earnings-per-share forecast amid regulatory uncertainty around Zyn nicotine pouches, rising competition and shipment pressure in the U.S. market.
PMI
Jun.02
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
China Tobacco Yunnan Patent Describes Cigar Flavor Granules With Encapsulation Rate Above 77%
According to public records from China’s National Intellectual Property Administration, a patent application filed by China Tobacco Yunnan Industrial Co., Ltd. for “cigar flavor granules” was published on May 12, 2026. The filing proposes purifying an ethanol extract of cigar tobacco leaves using LX-8 macroporous resin, followed by encapsulation with maltodextrin and sucrose fatty acid ester to improve smoking comfort, reduce dryness and enhance aroma release stability in reconstituted tobacco.
Jun.10
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Product | JT Upgrades with2 Infused Tobacco Capsules With Double-Size BIG PACK
Japan Tobacco Inc. (JT) announced that it will introduce a BIG PACK version of all five tobacco capsule variants designed for its with2 infused tobacco system. Scheduled for release in Japan on August 4, 2026, the refreshed packaging doubles the contents from five capsules and one cartridge to ten capsules and two cartridges while maintaining the same flavors and formulations
News
Jun.26 by 2Firsts Perspectives